CDK2 and cancer: Taken together, these results suggested that β-carboline-3-carboxylic acid dimers could arrest the cell cycle by suppressing TK1, DBF4, CCNA2, CDK2, and PLK1, together with influencing some cancer-related pathways to inhibit MG-63.